Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cornelia Liedtke"'
Publikováno v:
Breast Care. 11:275-281
Systemic therapy of metastatic breast cancer may include chemotherapy, endocrine therapy, and targeted therapies (e.g., antibody-based approaches). These agents may be employed alone or in combination based on the patient's breast cancer subtype. The
Autor:
JN Ingle, Cornelia Liedtke, Matthias Rübner, H Eidtmann, Jörn Hilfrich, Tanja Fehm, Michael Untch, J Huober, Christian Schem, Richard M. Weinshilboum, V Müller, Mahdi Rezai, Hans Tesch, S. Loibl, Bernd Gerber, G. von Minckwitz, Karsten Weber, Fergus J. Couch, S. D. Costa, J-U Blohmer, Valentina Nekljudova, Brigitte Rack, L Wang, PA Fasching
Publikováno v:
Cancer Research. 76:S5-06
Background: Mutations in BRCA1 and BRCA2 influence the molecular pathogenesis of breast cancer. However, little is known about the association between mutations, response to therapy, and prognosis. We therefore analysed these associations in triple n
Autor:
Rachel Wuerstlein, Michael J. Clemens, John Hackmann, M Warm, J. Potenberg, Matthias Christgen, Michael Braun, Karl Sotlar, A. Kohls, Claudia Schumacher, H.H. Kreipe, E Pelz, Nikola Bangemann, Christoph Lindner, Nadia Harbeck, P Staib, O Gluz, S. Kuemmel, Bahriye Aktas, Ronald E. Kates, Cornelia Liedtke, Helmut Forstbauer, U. Nitz, Christoph Uleer, E-M Grischke
Publikováno v:
Cancer Research. 76:S6-07
Background: Pathological complete response (pCR) is associated with improved prognosis in TNBC, but optimal chemotherapy remains unclear. Use of weekly nab- paclitaxel (Nab-Pac) vs. conventional paclitaxel and also addition of carboplatinum(Carbo) to